Introducing the society for immunotherapy of cancer’s new journal: journal for immunoTherapy of cancer
2013
The field of cancer immunology and immunotherapy is experiencing a tremendous increase in excitement and momentum, catalyzed by the latest approvals of immunotherapy-based treatments in multiple cancer types. Contributing to the excitement, more cancer vaccine candidates, immunomodulatory monoclonal antibodies and cellular therapies are showing great promise and major pharma companies are driving their development into future novel cancer treatments. Through extensive research and discussion among both the base and the leadership of the Society for Immunotherapy of Cancer (SITC) in the last several years, it became clear to SITC that there was a need for a targeted and broadly-accessible publication platform dedicated to advancing the science of tumor immunology and cancer immunotherapy. To fulfill this need and enrich communication between the many stakeholders in the tumor immunology and cancer immunotherapy community, SITC has created the Journal for ImmunoTherapy of Cancer (JITC). This new journal will serve the cancer immunotherapy community, to be our community’s outlet for the publication of original research articles, literature reviews, opinion/position papers and to be the prime forum to discuss the critical issues in tumor immunology and cancer immunotherapy research. The editorial board was constituted to bring together outstanding leaders in both basic and clinical tumor immunology and cancer immunotherapy fields, and will be focused on processing manuscripts and steering the journal in its initial stages in close collaboration with SITC. The journal is owned by the SITC. It is a joint venture with BioMed Central (BMC) -- a major power house in open access publishing, which organizes 250 peer-reviewed open access journals. What do we offer our authors? First, we strive to publish high quality papers after an efficient peer review process that adheres to the principles of fairness and scientific excellence. We welcome original contributions in the following areas:
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
4
References
9
Citations
NaN
KQI